# Oscar Health account plan

> Oscar Health is a US ACA individual-market health insurer with 2,691,885 members and a $19.0-$19.3 billion 2026 revenue outlook.

## At a glance

Oscar Health, Inc. (NYSE: OSCR), founded in 2012, sells health insurance in the US ACA individual market to individuals, families and employees whose employers offer ICHRA (which Oscar calls CHOICE), on its own cloud-native technology platform. It now describes itself as "a leading consumer healthcare company" serving consumers, employers, brokers and partners through Oscar Insurance and its Marketplace Subsidiaries (Lucie, Trove Group and HealthInsurance.org). In FY2025 total revenue was $11,701,427 thousand with a net loss attributable to Oscar of $443,151 thousand; nine-month 2026 net income attributable to Oscar reached $1,208,085 thousand. It had about 2,305 employees at December 31, 2025 and 2,691,885 effectuated members at September 30, 2026, concentrated in Florida, Texas and Georgia.

## Business units

- **Oscar Insurance** (Premium revenue $11,469,893 thousand in FY2025 (about 98% of total revenue, computed)): ACA individual-market plans in five metal tiers plus condition-targeted products, sold mostly through brokers, on exchange, off exchange and through CHOICE. Membership grew 27% to 2,691,885 at September 30, 2026, across 20 states for 2026. It is led by Janet Liang, President of Oscar Insurance.
- **Lucie Health Marketplace and brokerage**: Built from the May 2025 purchases of Lucie (a CMS-approved direct enrollment platform), IHC Specialty Benefits (brokerage) and Healthinsurance.org (consumer education and lead generation). Lucie is payer-agnostic with 70+ carriers and targets 2.6 million ACA and specialty products sold and 28,000 active brokers by 2029; management calls it a $150 million revenue opportunity per 100,000 members.
- **+Oscar Platform**: Sells Oscar's technology to providers and payors, mainly Campaign Builder, an engagement and recommendation platform using predictive analytics and AI. It serves nearly 0.6 million client lives in addition to Oscar's own members.

## Strategic priorities

- **Lead the individual market**: Oscar's long-term vision is to build the consumer marketplace of the future and lead the individual market, with a target of 18% national ACA market share by 2029 and its TAM growing from 9.6 million to 16 million.
- **CHOICE (ICHRA) growth**: Oscar wants to be the preferred carrier for employees enrolling through ICHRA; management sees half a million Choice lives in 2026 rising to 2.5 million by 2029.
- **Footprint expansion for 2027**: A 24% larger footprint spanning 713 counties and entry into South Carolina, plus about 850,000 lives coming to market from competitor exits, support share gains in 2027 alongside a weighted average rate increase of about 14%.
- **AI-native operations**: About two-thirds of production code is now written by coding agents, giving 2-3x faster time to market, and the Oswell AI agent resolves 30%-40% of member messages; the SG&A ratio reached a record-low 14% in Q3 2026.
- **Long-term financial targets**: Oscar targets operating margin above 5% and EPS above $2.25 in 2027, and revenue CAGR above 20%, a 5%-7% operating margin and EPS above $4 by 2029.

## Latest results

In Q3 2026 (quarter to September 30, 2026) total revenue rose to $5,139,298 thousand from $2,985,984 thousand, including a $250 million benefit from updated risk adjustment estimates. Earnings from operations were $178,018 thousand against a loss of $129,250 thousand, and net income attributable to Oscar was $167.3 million ($0.49 diluted EPS). The MLR improved to 84.0% from 88.5% on disciplined pricing and the SG&A ratio to 14.0% from 17.5%. Over nine months, net income attributable to Oscar was $1,208,085 thousand with an MLR of 78.1%. The FY2026 outlook was raised for a third time: total revenue $19.0-$19.3 billion, MLR 80.5%-81.5% and earnings from operations $850-$950 million.

## Investments and deals

- **Marketplace acquisitions**: In May 2025 Oscar acquired Lucie, IHC Specialty Benefits and Healthinsurance.org as building blocks of its ICHRA and consumer marketplace strategy.
- **Florida HMO subsidiary**: Oscar contributed $500.0 million to Oscar Health Maintenance Organization of Florida, Inc., which began writing insurance in 2026.
- **Financing**: Oscar issued $410.0 million of 2.25% convertible notes due 2030 in September 2025, exchanged most 2031 notes into stock, and signed a $475.0 million revolving credit facility on February 6, 2026, undrawn at September 30, 2026.
- **New products**: Launches include RetireEase for early retirees, dental and vision bundles, an Allstate Health Solutions supplemental pairing, Hy-Vee Health with Oscar expanding to Nebraska, Missouri and Kansas, and HelloMeno off-exchange.

## Challenges and risks

- **Expired enhanced subsidies**: The enhanced APTCs expired at the end of 2025, which Oscar believes made coverage unaffordable for some individuals and reduced marketplace participation and its own membership since the end of the 2026 OEP.
- **Program integrity and enrollment friction**: From October 12, 2026, EDE platforms must ID-proof certain consumers before brokers enroll them, and CMS eligibility reviews are removing members; Oscar expects about 2.5 million members at year-end.
- **Risk adjustment and morbidity estimates**: Risk adjustment estimates rely on third-party data and swung FY2025 into a loss when the MLR rose to 87.4% from 81.7%.
- **Geographic and broker concentration**: Membership is concentrated in Florida, Texas and Georgia, and distribution depends heavily on brokers.
- **Pharmaceutical tariffs**: 100% tariffs on patented pharmaceuticals from April 2, 2026 could make pharmaceutical rebates fall faster than drug costs, raising the MLR.

## What leadership says

> "Oscar Health is on track to deliver the strongest year of financial performance in our history, and we are raising our earnings from operations outlook for a third time." — Mark Bertolini, Chief Executive Officer, Q3 2026 results release, November 5, 2026

> "The era of employer health insurance is ending" — Mark Bertolini, Chief Executive Officer, Investor Day 2026, September 16, 2026

> "growing impact of AI that we are deploying across the business" — Scott Blackley, Chief Financial Officer, On Q3 SG&A, Q3 2026 earnings call, November 5, 2026

> "Claims, service, clinical workflows, member experience. It's all the same codes, the same foundation, the same monorepo." — Mario Schlosser, co-founder, Investor Day 2026, September 16, 2026


## Where a supplier can help

- **Broker enablement and ID proofing**: Tied to the program integrity challenge: tools that keep brokers productive under the new ID-proofing and eligibility rules support Lucie and Oscar's broker-led distribution.
- **Employer CHOICE adoption**: Tied to the CHOICE growth priority: benefits platforms, payroll and HR partners that help employers move to ICHRA feed Oscar's target of 2.5 million Choice lives by 2029.
- **Expansion into new markets**: Tied to the 2027 footprint expansion: provider network, marketing and member onboarding services for 713 counties and South Carolina support share gains.
- **Supplemental and consumer health products on Lucie**: Tied to the Lucie Health Marketplace: carriers and supplemental product providers can reach brokers and consumers through a payer-agnostic platform.
- **Pharmacy and medical cost control**: Tied to the risk adjustment and tariff challenges: pharmacy cost, claims review and data services address MLR pressure.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Form 10-K for fiscal year 2025](https://www.sec.gov/Archives/edgar/data/1568651/000156865126000011/oscr-20251231.htm)

Annual report · 2026-02-13

- Oscar Health is a US health insurer built on its own cloud-native "full stack technology platform", selling ACA individual-market plans to individuals, families and employees (including through ICHRA); approximately 2.0 million effectuated members at December 31, 2025 (2,042,449, up from 1,676,970).
- FY2025 total revenue was $11,701,427 thousand (vs $9,177,564 thousand in 2024); premium revenue rose 28% on above-market growth during the 2025 Open Enrollment.
- FY2025 swung to a loss: loss from operations of $396,357 thousand (vs earnings of $57,265 thousand) and a net loss attributable to Oscar of $443,151 thousand (vs net income of $25,432 thousand), as MLR rose to 87.4% from 81.7% on higher average market morbidity, a larger risk adjustment transfer accrual and higher utilization.
- SG&A expense ratio improved 160 basis points to 17.5% (from 19.1%) on fixed-cost leverage, lower exchange fee rates and disciplined cost management.
- Heavy geographic concentration: Florida (1,179,934 members), Texas (358,910) and Georgia (218,746); 18 states in 2025, expanded to 20 states for 2026; 93% of premiums came directly from CMS.
- Strategy: "build the consumer marketplace of the future and lead the individual market"; ICHRA is the main growth bet, supported by the May 2025 purchases of Lucie (EDE enrollment platform), IHC Specialty Benefits (brokerage) and Healthinsurance.org.
- +Oscar sells the Campaign Builder engagement platform to providers and payors (nearly 0.6 million client lives); AI is embedded in claims, virtual care, personalization and member-facing agents.
- Key risks: expiry of the enhanced APTCs at end-2025, CMS Program Integrity Rules and the OBBBA shrinking the marketplaces, risk adjustment estimates, and capital needs (excess statutory capital fell to an estimated ~$315 million from $734 million).
- Financing: $410.0 million 2.25% convertible notes due 2030 issued September 2025, most 2031 notes exchanged into stock, and a $475.0 million revolving credit facility signed February 6, 2026; about 2,305 employees; CEO Mark T. Bertolini, CFO R. Scott Blackley.

### [Form 10-Q for the quarter ended September 30, 2026](https://www.sec.gov/Archives/edgar/data/1568651/000156865126000086/oscr-20260930.htm)

Interim report · 2026-11-05

- Form 10-Q for Q3 2026: Oscar now describes itself as "a leading consumer healthcare company" serving consumers, employers, brokers and partners through Oscar Insurance and its Marketplace Subsidiaries (Lucie, Trove Group, HealthInsurance.org).
- About 2.7 million effectuated members at September 30, 2026 (2,691,885), up 27% year on year on above-market growth during the 2026 OEP and strong retention.
- Q3 premium revenue up 72% ($5,041,987 thousand) and nine-month premium up 65%, on rate increases and membership; MLR 84.0% (Q3) and 78.1% (nine months).
- Q3 earnings from operations $178,018 thousand vs a $129,250 thousand loss; nine-month net income attributable to Oscar $1,208,085 thousand.
- SG&A ratio 14.0% in Q3 (down 350 basis points) and 14.4% for nine months (down 290 basis points), helped by fixed-cost leverage and disciplined expense management.
- Balance sheet: $8.6 billion of cash and investments in the insurance subsidiaries, statutory capital and surplus of about $2.3 billion with about $1.4 billion of excess capital; $500.0 million put into a new Florida HMO subsidiary; nine-month operating cash flow $3.5 billion.
- Regulatory headwinds: expired enhanced APTCs, the 2027 NBPP income verification rules (stayed by a court on July 16, 2026), CMS ID proofing on EDE platforms from October 12, 2026, CMS member removals, and 100% tariffs on patented pharmaceuticals.

### [Oscar Health Announces Financial Results for Third Quarter 2026 and Raises Full Year 2026 Outlook](https://www.sec.gov/Archives/edgar/data/1568651/000156865126000082/oscarhealththirdquarter202.htm)

Interim report · 2026-11-05

- Q3 2026 total revenue approximately $5.1 billion ($5,139,298 thousand) vs $3.0 billion in Q3 2025, driven by rate increases and higher membership; it includes a $250 million benefit from updated risk adjustment estimates.
- Q3 earnings from operations $178.0 million vs a loss of $129.3 million; net income attributable to Oscar $167.3 million ($0.49 diluted EPS) vs a loss of $137.5 million ($(0.53)); adjusted EBITDA $206.9 million.
- MLR 84.0% vs 88.5%, on disciplined pricing; SG&A expense ratio 14.0% vs 17.5%.
- Nine months: total revenue $14,666,712 thousand, earnings from operations $1,270,738 thousand, net income attributable to Oscar $1,208,085 thousand, MLR 78.1%, SG&A ratio 14.4%.
- 2,691,885 effectuated members at September 30, 2026 vs 2,116,904 a year earlier.
- FY2026 outlook raised: total revenue $19.0-$19.3 billion (from $18.7-$19.0 billion), MLR 80.5%-81.5% (from 81.0%-82.0%), SG&A ratio 15.1%-15.6% (from 15.6%-16.1%), earnings from operations $850-$950 million (from $600-$800 million).
- CEO Mark Bertolini: Oscar is "on track to deliver the strongest year of financial performance in our history" and positioned "to grow market share and expand margin in 2027".

### [Oscar Health Q3 2026 earnings call transcript](https://stockanalysis.com/stocks/oscr/transcripts/726258-q3-2026/)

Executive talk · Mark Bertolini, Chief Executive Officer · 2026-11-05

- Q3 2026 earnings call (November 5, 2026), CEO Mark Bertolini and CFO Scott Blackley: "2026 is the strongest year in Oscar Health's history", with nine-month earnings from operations of $1.3 billion and net income of $1.2 billion.
- FY2026 earnings from operations guidance raised for a third time to $850-$950 million; several 2024 Investor Day commitments expected one year ahead of plan.
- Q3: revenue up roughly 70% to $5.1 billion, SG&A ratio a record-low 14% (helped by "AI-driven efficiencies"), MLR 84%, operating margin 3.5%.
- 2.7 million members, up 27%; expected ~2.5 million at year-end after CMS eligibility disenrollments.
- 2027: weighted average rate increase of ~14% (trend in the high single digits, market morbidity, some margin), stable ACA membership expected, market share gains from a 24% larger footprint (713 counties, South Carolina, ~10 million consumers across 21 states) and ~850,000 lives from competitor exits.
- New products: RetireEase for early retirees, dental/vision bundles, Allstate Health Solutions supplemental pairing, Hy-Vee Health with Oscar expanding to Nebraska, Missouri and Kansas, HelloMeno off-exchange; Lucie on track to sell ~800,000 new policies in 2027.
- Long-term target reaffirmed: at least $4 EPS by 2029; Bertolini supports program integrity and proposes KYC-based "wallets" to grow the ACA.

### [Oscar Health Investor Day 2026 transcript](https://stockanalysis.com/stocks/oscr/transcripts/718779-investor-day-2026/)

Executive talk · Mark Bertolini, Chief Executive Officer · 2026-09-16

- Investor Day 2026 (September 16, 2026) with CEO Mark Bertolini, CFO Scott Blackley, Janet Liang (President of Oscar Insurance) and co-founder Mario Schlosser.
- 2026 earnings from operations guidance raised to $600-$800 million (from $500-$700 million); MLR guidance improved 50 basis points to 81%-82%.
- 2029 targets: revenue CAGR above 20%, 5%-7% operating margin, EPS above $4; 2027: operating margin above 5% and EPS above $2.25; ACA market expected to grow from ~17 million lives (end-2026) to ~23 million by 2029.
- Aim: 18% national ACA market share by 2029, Oscar TAM from 9.6 million to 16 million via in-market share (30% to 35%), 400-600 new counties a year and CHOICE (ICHRA).
- Lucie Health Marketplace: payer-agnostic platform with 70+ carriers, targeting 2.6 million ACA and specialty products sold and 28,000 active brokers by 2029; $150 million revenue opportunity per 100,000 members; margins "five to six times greater" than insurance.
- AI: ~two-thirds of code now written by coding agents, 2-3x faster time to market; Oswell AI agent resolves 30%-40% of member messages; $3 billion of affordability over two years.
- Plan to generate $4-$4.5 billion of capital; ~60% retained in insurers, ~40% to the parent for M&A and dilution management.

## Questions about Oscar Health

### What does Oscar Health do?

Oscar Health sells ACA individual-market health insurance to individuals, families and ICHRA employees on its own technology platform, and runs the Lucie Health Marketplace and brokerage businesses.

### What is Oscar Health's revenue?

FY2025 total revenue was $11,701,427 thousand. For 2026 Oscar guides total revenue of $19.0-$19.3 billion, after nine-month revenue of $14,666,712 thousand.

### How many members and employees does Oscar Health have?

Oscar had 2,691,885 effectuated members at September 30, 2026 and about 2,305 employees at December 31, 2025.

### What is Oscar Health's strategy?

Oscar aims to lead the individual market, grow CHOICE (ICHRA) membership, expand its footprint, build Lucie into a consumer health marketplace and run as an AI-native carrier, targeting EPS above $4 by 2029.

### Who leads Oscar Health?

Mark Bertolini is CEO, Scott Blackley is CFO, Janet Liang is President of Oscar Insurance and Mario Schlosser is co-founder.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
